134 related articles for article (PubMed ID: 6087827)
1. Metabolism of arabinosyladenine in herpes simplex virus-infected and uninfected cells. Correlation with inhibition of DNA synthesis and role in antiviral selectivity.
Schwartz PM; Novack J; Shipman C; Drach JC
Biochem Pharmacol; 1984 Aug; 33(15):2431-8. PubMed ID: 6087827
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor.
Schwartz PM; Shipman C; Drach JC
Antimicrob Agents Chemother; 1976 Jul; 10(1):64-74. PubMed ID: 185947
[TBL] [Abstract][Full Text] [Related]
3. The selective inhibition of viral DNA synthesis by chemotherapeutic agents: an indicator of clinical usefulness?
Drach JC; Shipman C
Ann N Y Acad Sci; 1977 Mar; 284():396-409. PubMed ID: 212984
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures.
Shipman C; Smith SH; Carlson RH; Drach JC
Antimicrob Agents Chemother; 1976 Jan; 9(1):120-7. PubMed ID: 176927
[TBL] [Abstract][Full Text] [Related]
5. Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine.
Smith SH; Shipman C; Drach JC
Cancer Res; 1978 Jul; 38(7):1916-21. PubMed ID: 207416
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1.
Williams BB; Bailey EJ; Lerner AM
J Lab Clin Med; 1977 Apr; 89(4):687-91. PubMed ID: 191546
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of arabinosylthymine in herpesviral replication: mechanism of action in vivo and in vitro.
Aswell JF; Allen GP; Jamieson AT; Campbell DE; Gentry GA
Antimicrob Agents Chemother; 1977 Aug; 12(2):243-54. PubMed ID: 197886
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of herpesvirus DNA synthesis by 9-beta-D-arabinofuranosyladenine in cellular and cell-free systems.
Müller WE; Zahn RK; Bittlingmaier K; Falke D
Ann N Y Acad Sci; 1977 Mar; 284():34-48. PubMed ID: 212980
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus.
Williams BB; Lerner AM
J Infect Dis; 1975 Jun; 131(6):673-7. PubMed ID: 166117
[TBL] [Abstract][Full Text] [Related]
10. In vitro metabolism of 1-beta-D-arabinofuranosylcytosine and 1-beta-2'-fluoroarabino-5-iodocytosine in normal and herpes simplex type 1 virus-infected cells.
Kreis W; Damin L; Colacino J; Lopez C
Biochem Pharmacol; 1982 Mar; 31(5):767-73. PubMed ID: 7082345
[TBL] [Abstract][Full Text] [Related]
11. Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine.
Plunkett W; Benjamin RS; Keating MJ; Freireich EJ
Cancer Res; 1982 May; 42(5):2092-6. PubMed ID: 6175407
[TBL] [Abstract][Full Text] [Related]
12. Differential and selective inhibition of cellular and herpes simplex virus DNA synthesis by arabinofuranosyladenine.
Falke D; Ronge K; Arendes J; Müller WE
Biochim Biophys Acta; 1979 Jun; 563(1):36-45. PubMed ID: 227462
[TBL] [Abstract][Full Text] [Related]
13. DNA polymerase in nuclei isolated from herpes simplex virus type-2-infected cells. Characterization of the reaction product and inhibition by substrate analogs.
Barnett JW; Reinke CM; Turk SR; Drach JC
Biochim Biophys Acta; 1984 Feb; 781(1-2):130-42. PubMed ID: 6320890
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus mutants resistant to arabinosyladenine in the presence of deoxycoformycin.
Fleming HE; Coen DM
Antimicrob Agents Chemother; 1984 Sep; 26(3):382-7. PubMed ID: 6095755
[TBL] [Abstract][Full Text] [Related]
15. Enhanced survival of ultraviolet-irradiated herpes simplex virus in cells exposed to antiviral agents.
Schnipper LE; Lewin AA; Crumpacker CS
Mutat Res; 1983 Feb; 116(2):65-72. PubMed ID: 6298618
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the anti-herpesvirus drug combinations: virazole plus arabinofuranosylhypoxanthine and virazole plus arabinofuranosyladenine.
Allen LB; Vanderslice LK; Fingal CM; McCright FH; Harris EF; Cook PD
Antiviral Res; 1982 Sep; 2(4):203-16. PubMed ID: 6293375
[TBL] [Abstract][Full Text] [Related]
17. Correlation of cytotoxicity with total intracellular exposure to 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
Shewach DS; Plunkett W
Cancer Res; 1982 Sep; 42(9):3637-41. PubMed ID: 6179604
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
Kufe D; Herrick D; Crumpacker C; Schnipper L
Cancer Res; 1984 Jan; 44(1):69-73. PubMed ID: 6317173
[TBL] [Abstract][Full Text] [Related]
19. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
20. Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells.
Smee DF; Boehme R; Chernow M; Binko BP; Matthews TR
Biochem Pharmacol; 1985 Apr; 34(7):1049-56. PubMed ID: 3872662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
